SYNTHOMER INC. – Trademark Portfolio
Entity Type: 03
SYNTHOMER INC. holds 47 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 43 filings in this category. The portfolio also extends into Class 17 (Rubber Goods) across 5 Nice Classification classes. Currently, 42 trademarks are registered. Notable registered marks include MYKON, GENFLO, SUNREZ, GENCEAL, and GENCRYL. The owner is based in BEACHWOOD, OH.
25435 HARVARD ROAD
BEACHWOOD, OH 44122-6201
Showing of trademarks Trademarks
Trademark Classifications
SYNTHOMER INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does SYNTHOMER INC. have?
SYNTHOMER INC. has 47 U.S. trademarks filed with the USPTO. Of these, 42 registered, 5 cancelled.
What trademark classes does SYNTHOMER INC. file in?
SYNTHOMER INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 17 (Rubber Goods), Class 3 (Cosmetics & Cleaning), Class 27 (Floor Coverings), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are SYNTHOMER INC.'s most well-known trademarks?
SYNTHOMER INC.'s registered trademark portfolio includes well-known marks such as MYKON, GENFLO, SUNREZ, GENCEAL, and GENCRYL. These are among 42 currently registered trademarks in the portfolio.
What is SYNTHOMER INC.'s trademark registration success rate?
SYNTHOMER INC. has a 89% trademark registration rate, with 42 out of 47 resolved applications resulting in successful registration. Currently, 0 applications are pending review.